Company / FCF Margin
Viridian Therapeutics, Inc.\DE FCF Margin History
FY2016-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-6150.0%
FY2017
5-year range
-
FY2016-FY2017
Trend
-1325.1%
vs FY2016
Sector context
#132 of 134
Health Care
What the data says
Among 134 Health Care companies, Viridian Therapeutics, Inc.\DE is in the bottom 1% for fcf margin.
Based on SEC 10-K filings.
-6150.0% in FY2017.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Bottom 1% in Health CareTop 99% of 134This company -6150.0% Sector average -637.8%
▼
-864.3% below sector average
Key checks
Key Insights
- In FY2017, fcf margin decreased 1325.1% year-over-year.
- Currently 5512.2pp below the Health Care sector average.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 1.11 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | -6150.0% | -1325.1% |
| FY2016 | -431.6% | -250.7% |
As of FY2017 · SEC 10-K · Updated Jun 30, 2026